Harvard Bioscience Inc (HBIO)
2.22
+0.06
(+2.78%)
USD |
NASDAQ |
Nov 22, 10:54
Harvard Bioscience Max Drawdown (5Y): 78.81% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 78.81% |
| September 30, 2024 | 78.81% |
| August 31, 2024 | 78.81% |
| July 31, 2024 | 78.81% |
| June 30, 2024 | 78.81% |
| May 31, 2024 | 78.81% |
| April 30, 2024 | 78.81% |
| March 31, 2024 | 78.81% |
| February 29, 2024 | 78.81% |
| January 31, 2024 | 78.81% |
| December 31, 2023 | 78.81% |
| November 30, 2023 | 78.81% |
| October 31, 2023 | 78.81% |
| September 30, 2023 | 78.81% |
| August 31, 2023 | 78.81% |
| July 31, 2023 | 78.81% |
| June 30, 2023 | 78.81% |
| May 31, 2023 | 78.81% |
| April 30, 2023 | 78.81% |
| March 31, 2023 | 78.81% |
| February 28, 2023 | 78.81% |
| January 31, 2023 | 78.81% |
| December 31, 2022 | 78.81% |
| November 30, 2022 | 78.81% |
| October 31, 2022 | 78.81% |
| Date | Value |
|---|---|
| September 30, 2022 | 78.81% |
| August 31, 2022 | 78.81% |
| July 31, 2022 | 78.81% |
| June 30, 2022 | 78.81% |
| May 31, 2022 | 78.81% |
| April 30, 2022 | 78.81% |
| March 31, 2022 | 78.81% |
| February 28, 2022 | 78.81% |
| January 31, 2022 | 78.81% |
| December 31, 2021 | 78.81% |
| November 30, 2021 | 78.81% |
| October 31, 2021 | 78.81% |
| September 30, 2021 | 78.81% |
| August 31, 2021 | 78.81% |
| July 31, 2021 | 78.81% |
| June 30, 2021 | 78.81% |
| May 31, 2021 | 78.81% |
| April 30, 2021 | 78.81% |
| March 31, 2021 | 78.81% |
| February 28, 2021 | 78.81% |
| January 31, 2021 | 78.81% |
| December 31, 2020 | 78.81% |
| November 30, 2020 | 78.81% |
| October 31, 2020 | 78.81% |
| September 30, 2020 | 78.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
76.27%
Minimum
Nov 2019
78.81%
Maximum
Mar 2020
78.64%
Average
78.81%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Bruker Corp | 46.31% |
| Azenta Inc | 70.61% |
| Bionano Genomics Inc | -- |
| Akoya Biosciences Inc | -- |
| Singular Genomics Systems Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -22.70 |
| Beta (5Y) | 1.308 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 61.02% |
| Historical Sharpe Ratio (5Y) | -0.0952 |
| Historical Sortino (5Y) | -0.1937 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.19% |